Sam Altman says Elon Musk wanted 90 percent of OpenAI in high-stakes trial

Sam Altman testified in OpenAI's trial against Elon Musk, who is seeking $150bn in damages and the removal of Altman and Greg Brockman over claims OpenAI abandoned its charitable mission. Altman countered that Musk knew about the for-profit direction and even sought 90% of OpenAI's equity at one point. The case could affect OpenAI's leadership, ChatGPT, and a potential IPO that has been reported could value the company at $1 trillion.

Analysis

The market is treating this as a legal event, but the bigger tradable issue is control premium compression. If the court narrative continues to paint OpenAI as founder-fragile, any IPO or late-stage private round gets a governance discount, and Microsoft is the only obvious public proxy with direct exposure. That matters because MSFT’s AI multiple is increasingly tied to OpenAI’s credibility as an asset-light model supplier; even a small increase in perceived control/continuity risk can shave multiple turns off the AI increment before any operating data changes.

Near term, the key catalyst is not the verdict itself but the cadence of testimony and whether it forces disclosure around ownership, board rights, and commercialization timelines. That creates a two-sided setup: headline risk can pressure MSFT in the next 1-4 weeks, but a clean defense of OpenAI’s for-profit structure could quickly re-open the IPO/valuation trade and lift AI-exposed software names. The asymmetry is that downside on governance uncertainty is immediate, while upside from a favorable ruling likely takes months to show up in capital markets.

The second-order effect is that a messy trial may actually strengthen the broader AI capex complex, because hyperscalers can position themselves as the steadier governance alternative to frontier-model startups. If private-market funding for OpenAI becomes more expensive or slower, demand should shift toward Microsoft, Google, and internal model development, which is mildly bearish for pure-play AI infrastructure optimism but supportive for the biggest balance sheets. The consensus is probably underpricing how much legal uncertainty can delay an IPO and reduce the optionality embedded in OpenAI-linked assets without changing the product story at all.

For now, this is more a volatility and relative-value event than a fundamental earnings event. The market should fade absolute moves until there is a real signal on ownership/control, but the path of least resistance is lower for the name most exposed to OpenAI governance headlines.

Key Decisions for Investors

• Short MSFT into trial headlines on a 1-4 week horizon via put spreads; target a modest drawdown if governance risk widens, with defined premium risk if testimony turns quickly in OpenAI's favor.
• Pair trade: long GOOGL / short MSFT for the next 2-6 weeks if you expect OpenAI governance uncertainty to be a relative drag on Microsoft while Google benefits from the 'stable AI platform' narrative.
• Buy MSFT downside protection into the next major court milestone; use 1-2 month puts or put spreads as a cheap hedge against a trial-driven multiple compression event.
• If OpenAI IPO chatter resurfaces with clean governance signals, rotate from MSFT shorts to long AI infrastructure beneficiaries such as NVDA/ANET on the view that capital raises will re-accelerate model-training spend.